The Pharma Letter In clinical trials, fidaxomicin demonstrated a similar efficacy and safety profile to the current mainstay of therapy, vancomycin (primary endpoint), but more than halved the rate of recurrence in patients with CDI compared to vancomycin (planned ... and more »
globalnews.ca ... infection or colonization in patients from three bacterial microbes that have become immune to the killing effects of most or all antibiotics – MRSA (methicillin-resistant Staphylococcus aureus), VRE ( vancomycin -resistant Enterococci) and ... and more »
Healio WASHINGTON — Exposure of both azithromycin-susceptible and azithromycin-resistant community-associated methicillin-resistant Staphylococcus aureus isolates to azi...
Healio WASHINGTON — Vancomycin use increased from January 2006 to December 2011 even though there was no increase in methicillin-resistant Staphylococcus aureus or antibiotic-resistant coagulase-negative Staphylococcus bacteremia, according to study ...
Azom.com It is also well-documented that these pathogens, and others such as vancomycin -resistant Enterococcus and carbapenem-resistant Enterobacteriaceae, can persist on environmental surfaces for days, weeks and even months. This can lead to the ...
UB School of Medicine and Biomedical Sciences News ... (MRSA), the culprit behind lethal hospital-acquired staph infections. Its powerful effect also works against Streptococcus pneumoniae, which is resistant to penicillin, and strains of bacteria resistant to vancomycin , known as the “antibiotic of ...
Healio WASHINGTON — Exposure of both azithromycin-susceptible and azithromycin-resistant community-associated methicillin-resistant Staphylococcus aureus isolates to azithromycin/ vancomycin combinations led to a significantly reduced macrophage ...
Healio WASHINGTON — Vancomycin use increased from January 2006 to December 2011 even though there was no increase in methicillin-resistant Staphylococcus aureus or antibiotic-resistant coagulase-negative Staphylococcus bacteremia, according to study ...
Healio WASHINGTON — Exposure of both azithromycin-susceptible and azithromycin-resistant community-associated methicillin-resistant Staphylococcus aureus isolates to azithromycin/ vancomycin combinations led to a significantly reduced macrophage ...
